Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
International Journal of Oral Science ; (4): 48-48, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1010703

RESUMEN

Mesenchymal stem cell (MSC)-based therapy has emerged as a promising treatment for spinal cord injury (SCI), but improving the neurogenic potential of MSCs remains a challenge. Mixed lineage leukemia 1 (MLL1), an H3K4me3 methyltransferases, plays a critical role in regulating lineage-specific gene expression and influences neurogenesis. In this study, we investigated the role and mechanism of MLL1 in the neurogenesis of stem cells from apical papilla (SCAPs). We examined the expression of neural markers, and the nerve repair and regeneration ability of SCAPs using dynamic changes in neuron-like cells, immunofluorescence staining, and a SCI model. We employed a coimmunoprecipitation (Co-IP) assay, real-time RT-PCR, microarray analysis, and chromatin immunoprecipitation (ChIP) assay to investigate the molecular mechanism. The results showed that MLL1 knock-down increased the expression of neural markers, including neurogenic differentiation factor (NeuroD), neural cell adhesion molecule (NCAM), tyrosine hydroxylase (TH), βIII-tubulin and Nestin, and promoted neuron-like cell formation in SCAPs. In vivo, a transplantation experiment showed that depletion of MLL 1 in SCAPs can restore motor function in a rat SCI model. MLL1 can combine with WD repeat domain 5 (WDR5) and WDR5 inhibit the expression of neural markers in SCAPs. MLL1 regulates Hairy and enhancer of split 1 (HES1) expression by directly binds to HES1 promoters via regulating H3K4me3 methylation by interacting with WDR5. Additionally, HES1 enhances the expression of neural markers in SCAPs. Our findings demonstrate that MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1. These results provide a potential therapeutic target for promoting the recovery of motor function in SCI patients.


Asunto(s)
Animales , Humanos , Ratas , Diferenciación Celular , Péptidos y Proteínas de Señalización Intracelular/uso terapéutico , Leucemia/metabolismo , Células Madre Mesenquimatosas , Neurogénesis , Células Madre , Factor de Transcripción HES-1/metabolismo
2.
Journal of Experimental Hematology ; (6): 483-488, 2023.
Artículo en Chino | WPRIM | ID: wpr-982084

RESUMEN

OBJECTIVE@#To explore the effects of Ena/VASP gene family on the expression of glycoprotein (GP) Ib-IX complex in human megakaryoblastic leukemia Dami cells.@*METHODS@#SiRNAs targeting Ena/VASP gene family were designed and synthesized to interfere Enah, EVL and VASP gene expression. When the siRNAs were transfected into Dami cells by using LipofectamineTM 2000 for 48 h, the expression of GPIb-IX complex was detected by quantitative real-time PCR, Western blot and flow cytometry.@*RESULTS@#We successfully established siVASP , siEVL and si Enah Dami cell lines. And it was found that the expression of GPIb-IX complex had no evident reduction in siEVL or siVASP Dami cells at both mRNA and protein level, while the total protein and membrane protein of GPIb-IX complex were obviously reduced when Enah was knocked down.@*CONCLUSION@#Enah could affect the expression of GPIb-IX complex in human megakaryoblastic leukemia Dami cells, but the underlying mechanism still needs to be further explored.


Asunto(s)
Humanos , Línea Celular , Complejo GPIb-IX de Glicoproteína Plaquetaria/metabolismo , Leucemia/metabolismo , Plaquetas/metabolismo
3.
Journal of Experimental Hematology ; (6): 435-440, 2022.
Artículo en Chino | WPRIM | ID: wpr-928733

RESUMEN

OBJECTIVE@#To explore the expression levels and clinical significance of helper T cell 1/helper T cell 2 (Th1/Th2) cytokine and interleukin-6 (IL-6) in patients with acute leukemia (AL) complicated by infection.@*METHODS@#68 patients with AL complicated by infection admitted to Wuhan Fifth Hospital from May 2017 to January 2020 were enrolled as study group, 50 AL patients without infection were enrolled as AL group, and 30 healthy volunteers checked in physical examination center were enrolled as healthy control group. The levels of serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-10 (IL-10), and peripheral blood Th1/Th2 cells subsets were measured and compared among the three groups. The serum IL-6, IL-10, TNF-α and Th1/Th2 were compared between the patients with mild to moderate infection (n=52) and septic shock (n=16). The relationship between IL-6, IL-10, TNF-α, Th1/Th2 and AL infection was analyzed.@*RESULTS@#The levels of IL-6, IL-10 , TNF-α, and the proportion of Th2 of the patients in study group and AL group were significantly higher than those in healthy control group (P<0.001), while the proportion of Th1 and Th1/Th2 were significantly lower than those in healthy control group (P<0.001). The levels of IL-6, IL-10 and TNF-α, and the proportion of Th2 the patients in study group were significantly higher than those in AL group (P<0.001), while the proportion of Th1 and Th1/Th2 were significantly lower than those in AL group (P<0.001). The serum IL-6, IL-10 and TNF-α level of the patients in septic shock group were significantly higher than those in mild-to-moderate infection group (P<0.001), while Th1/Th2 was lower than those in mild-to-moderate infection group (P<0.001). The results of ROC curve analysis showed that the area under the ROC curve (AUC) values of IL-6, IL-10, TNF-α and Th1/Th2 alone for the diagnosis of septic shock were 0.779, 0.761, 0.724 and 0.718, which were lower than that their combination (0.910) (P<0.05).@*CONCLUSION@#The levels of serum IL-6, IL-10 and TNF-α are high in patients with AL complicated infection and septic shock, while Th1/Th2 cell subsets is low. The combined detection of serum IL-6, IL-10, TNF-α and Th1/Th2 is a good diagnostic value for predicting the occurrence of severe septic shock.


Asunto(s)
Humanos , Citocinas/metabolismo , Interleucina-10 , Interleucina-6/metabolismo , Leucemia/metabolismo , Choque Séptico/metabolismo , Células TH1/metabolismo , Células Th2/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
4.
China Journal of Chinese Materia Medica ; (24): 2541-2546, 2022.
Artículo en Chino | WPRIM | ID: wpr-928134

RESUMEN

To investigate the toxicity and related mechanism of miltirone to human acute myeloid leukemia THP-1 cells. To be specific, the active components and targets of miltirone were retrieved from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP), and the target proteins were converted into standard gene names with UniProt. Acute leukemia-rela-ted target genes were screened from GeneCards and DisGeNET. Venn diagram was constructed with Venny 2.1 to yield the common targets of the disease and the drug. The protein-protein interaction(PPI) network was constructed by STRING and Cytoscape 3.8.2. THP-1 cells in the logarithmic growth phase were treated with dimethyl sulfoxide(DMSO), and 2.5, 5, 10, 15, and 20 μmol·L~(-1) miltirone for 24 h, respectively. The proliferation rate of cells was analyzed by carboxyfluorescein diacetate succinimidyl ester(CFSE), apoptosis rate by flow cytometry with Annexin V-PE/7 AAD staining, and cell morphology by acridine orange staining. Real-time quantitative PCR(qPCR) was employed to detect the mRNA levels of nuclear receptor coactivator 2(NCOA2), poly(ADP-ribose) polymerase-1(PARP1), B-cell lymphoma-2(Bcl-2)-associated X protein(Bax), Bcl-2, and cysteine aspartyl protease-3(caspase-3). The effect of miltirone on apoptosis was detected in presence of caspase inhibitor Z-VAD-FMK. A total of 26 targets of miltirone, 1 046 genes related to acute leukemia, and 6 common targets of the two were screened out. Flow cytometry result showed miltirone at 10 μmol·L~(-1) can inhibit proliferation and promote apoptosis of THP-1 cells. The typical manifestations of apoptosis, such as cell shrinkage, nuclear rupture, and chromatin agglomerate were displayed by acridine orange staining. The decreased mRNA levels of NCOA2 and PARP1 and increased Bax/Bcl-2 ratio and the activity of pro-apoptotic protein caspase-3 were observed. Z-VAD-FMK can attenuate the apoptosis-inducing effect of miltirone. This study indicates that miltirone can inhibit the proliferation and promote the apoptosis of THP-1 cells, by down-regulating NCOA2 and PARP1, raising Bax/Bcl-2 ratio, and activating caspase-3.


Asunto(s)
Humanos , Apoptosis , Caspasa 3/metabolismo , Proliferación Celular , Leucemia/metabolismo , Fenantrenos/farmacología , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , ARN Mensajero , Células THP-1 , Proteína X Asociada a bcl-2/metabolismo
5.
Rev. bras. cancerol ; 64(4): 533-539, 2018.
Artículo en Portugués | LILACS | ID: biblio-1025287

RESUMEN

Introdução: As neoplasias hematológicas, leucemias e linfomas são patologias que afetam o sangue ou tecidos formadores dele. Durante o período de hospitalização, os pacientes podem desenvolver redução da capacidade funcional que pode interferir na sua função respiratória. Objetivo: Avaliar a influência do tempo de internamento sobre a força muscular respiratória e o nível funcional de adultos com leucemia e linfoma. Método: Estudo observacional, com delineamento longitudinal e abordagem quantitativa, realizado na enfermaria onco-hematológica do Complexo Hospitalar Universitário Professor Edgard Santos (Hupes). A avaliação da força muscular respiratória foi mensurada pelo manovacuômetro e a capacidade funcional pela escala de desempenho de Karnofsky (KPS). Resultados: No decorrer do tempo de internamento dos pacientes, houve uma diminuição da pressão expiratória máxima (PEM) (p=0,000), porém não foi observada diferença significativa na pressão inspiratória máxima (PIM) (p>0,05). Em relação à KPS, os pacientes apresentaram nível de funcionalidade de 70%. Conclusão: Este estudo demonstrou que a PEM foi alterada durante o internamento, porém não houve modificação da PIM e da funcionalidade dos pacientes.


Introduction: Hematologic neoplasms, leukemias and lymphomas are pathologies that affect the blood or tissues that form it. During the hospitalization period patients may develop functional capacity reduction, which may interfere with their respiratory function. Objective: Evaluate the influence of hospitalization time about respiratory muscle strength and functional level of adults with leukemia and lymphoma. Method: Observational study, with longitudinal design and quantitative approach, performed at the onco-hematological ward of the University Hospital Complex Professor Edgard Santos (Hupes). The assessment of respiratory muscle strength was measured using the manovacuometer and functional capacity using the Karnofsky Performance Scale (KPS). Results: During the hospitalization time, there was a decrease in the maximum expiratory pressure (PEM) (p=0.000), but no significant difference was observed in the maximum inspiratory pressure (PIM) (p>0.05). In relation to KPS, the patients presented functional level of 70%. Conclusion: This study demonstrated that PEM was altered during hospitalization, but there was no modification of the PIM and the functionality of the patients.


Introducción: Las neoplasias hematológicas, leucemias y linfomas son patologías que afectan a la sangre o tejidos formadores de él. Durante el período de hospitalización los pacientes pueden desarrollar una reducción de la capacidad functional, que puede interferer en su función respiratoria. Objetivo: Evaluar la influencia del tiempo de internamiento sobre la fuerza muscular respiratoria y nivel funcional de adultos con leucemia y linfoma. Método: Estudio observacional, con delineamiento longitudinal y el enfoque cuantitativo, realizado en la enfermería onco-hematológica del Complejo Hospitalario Universitario Profesor Edgard Santos (Hupes). La evaluación de la fuerza muscular respiratoria se midió utilizando el manovacuómetro y la capacidad funcional utilizando la escala de rendimiento de Karnofsky (KPS). Resultados: En el transcurso del tiempo de internamiento de los pacientes, hubo una disminución de la presión espiratoria máxima (PEM) (p=0,000), pero no se observó diferencia significativa en la presión inspiratoria máxima (PIM) (p>0,05). En relación a KPS, los pacientes presentaron un nivel de funcionalidad del 70%. Conclusión: Este estudio demostró que la PEM fue alterada durante el internamiento, pero no hubo modificación de la PIM y de la funcionalidad de los pacientes.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Leucemia/metabolismo , Neoplasias Hematológicas/complicaciones , Linfoma/metabolismo , Estado de Ejecución de Karnofsky , Fuerza Muscular , Tiempo de Internación
6.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 37(1): 49-54, Jan-Mar/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-741937

RESUMEN

Objective: Peritraumatic reactions feature prominently among the main predictors for development of posttraumatic stress disorder (PTSD). Peritraumatic tonic immobility (PTI), a less investigated but equally important type of peritraumatic response, has been recently attracting the attention of researchers and clinicians for its close association with traumatic reactions and PTSD. Our objective was to investigate the role of PTI, peritraumatic panic, and dissociation as predictors of PTSD symptoms in a cohort of police recruits (n=132). Methods: Participants were asked to complete the following questionnaires during academy training and after the first year of work: Posttraumatic Stress Disorder Checklist - Civilian Version (PCL-C), Physical Reactions Subscale (PRS), Peritraumatic Dissociative Experiences Questionnaire (PDEQ), Tonic Immobility Scale (TIS), and Critical Incident History Questionnaire. Results: Employing a zero-inflated negative binomial regression model, we found that each additional point in the TIS was associated with a 9% increment in PCL-C mean scores (RM = 1.09), whereas for PRS, the increment was 7% (RM = 1.07). As the severity of peritraumatic dissociation increased one point in the PDEQ, the chance of having at least one symptom in the PCL-C increased 22% (OR = 1.22). Conclusions: Our findings highlight the need to expand investigation on the incidence and impact of PTI on the mental health of police officers. .


Asunto(s)
Animales , Humanos , Ratones , Proteínas Cromosómicas no Histona/fisiología , Leucemia/patología , Proteína de la Leucemia Mieloide-Linfoide/genética , Células Madre Neoplásicas/patología , Oncogenes , Proteínas Represoras/fisiología , Apoptosis , Proteínas Cromosómicas no Histona/genética , Citometría de Flujo , Leucemia/genética , Leucemia/metabolismo , Reacción en Cadena de la Polimerasa , Proteínas Represoras/genética
7.
Artículo en Inglés | IMSEAR | ID: sea-139911

RESUMEN

Background: Leukemia is a fatal disease. The oral manifestations of the leukemias occur early in the course of the disease and these oral features can at times act as a diagnostic indicator. Saliva has been used as a diagnostic aid in a number of systemic diseases. Materials and Methods: In our study, samples of unstimulated saliva of 30 leukemia patients who were not on chemotherapy were collected and analyzed for salivary amylase and total protein. The oral manifestations and radiographic changes (OPG) were recorded. The correlation between the oral manifestations and the salivary components (salivary amylase and total protein) was assessed for prognostic significance. Results: In the present study when the mean values of salivary amylase (1280±754 U/ml) and total protein (647.2±320.7 mg%) were compared with that in control subjects. There was a statistically significant difference for amylase levels (P<.05). On intraoral examination the study subjects showed pallor, gingivitis, gingival enlargement, petechiae, and ecchymosis. On the OPG, the radiographic features included generalized rarefaction of bone (20%), thinning of lamina dura (3.4%), generalized alveolar crest bone resorption (30%), thinning of walls of alveolar crypts (6.7%), besides others, e.g., periapical abscess (10%). Conclusions: The saliva of leukemic patients demonstrated obvious changes in composition. A rise in salivary amylase and total protein levels was evident, with the increase in amylase levels being statistically significant.


Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Pérdida de Hueso Alveolar/etiología , Pérdida de Hueso Alveolar/diagnóstico por imagen , Amilasas/análisis , Estudios de Casos y Controles , Niño , Preescolar , Equimosis/etiología , Femenino , Hipertrofia Gingival/etiología , Gingivitis/etiología , Humanos , Enfermedades Maxilomandibulares/etiología , Enfermedades Maxilomandibulares/diagnóstico por imagen , Leucemia/complicaciones , Leucemia/metabolismo , Leucemia Linfocítica Crónica de Células B/complicaciones , Leucemia Linfocítica Crónica de Células B/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/complicaciones , Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo , Leucemia Mieloide Aguda/complicaciones , Leucemia Mieloide Aguda/metabolismo , Masculino , Persona de Mediana Edad , Enfermedades de la Boca/etiología , Absceso Periapical/etiología , Absceso Periapical/diagnóstico por imagen , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/metabolismo , Púrpura/etiología , Radiografía Panorámica , Saliva/enzimología , Proteínas y Péptidos Salivales/análisis , Adulto Joven
8.
Journal of Korean Medical Science ; : 815-819, 2007.
Artículo en Inglés | WPRIM | ID: wpr-176606

RESUMEN

The house dust mite (HDM) is considered to be the most common indoor allergen associated with bronchial asthma. In this study, we investigated whether crude extract of the HDM Dermatophagoides farinae could activate human eosinophilic leukemic cells (EoL-1) to induce upregulation of cell-surface adhesion molecules. When EoL-1 cells were incubated with D. farinae extract, expression of intercellular adhesion molecule-1 (ICAM-1) significantly increased on the cell surfaces compared to cells incubated with medium alone. In contrast, surface expression of CD11b and CD49d in EoL-1 cells was not affected by D. farinae extract. In addition, pretreatment of cells with NF- kappaB inhibitor (MG-132) or JNK inhibitor (SP600125) significantly inhibited ICAM-1 expression promoted by HDM extract. However, neither p38 MAP kinase inhibitor nor MEK inhibitor prevented HDM-induced ICAM-1 expression in EoL-1 cells. These results suggest that crude extract of D. farinae induces ICAM-1 expression in EoL-1 cells through signaling pathways involving both NF- kappaB and JNK.


Asunto(s)
Animales , Humanos , Antracenos/farmacología , Antígeno CD11b/biosíntesis , Línea Celular Tumoral , Membrana Celular/metabolismo , Eosinófilos/metabolismo , Citometría de Flujo/métodos , Regulación de la Expresión Génica , Integrina alfa4/biosíntesis , Molécula 1 de Adhesión Intercelular/metabolismo , Leucemia/metabolismo , Leupeptinas/farmacología , Proteína Quinasa 8 Activada por Mitógenos/metabolismo , FN-kappa B/metabolismo , Pyroglyphidae , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
9.
Experimental & Molecular Medicine ; : 174-178, 1999.
Artículo en Inglés | WPRIM | ID: wpr-158709

RESUMEN

Tanshinone II-A is a derivative of phenanthrene-quinone isolated from Salvia miltiorrhiza BUNGE, a traditional herbal medicine that is known to induce antiinflammatory, anti-oxidative and cytotoxic activity. We have examined cellular effects of Tanshione II-A on HL60 human promyelocytic leukemic cells and K562 human erythroleukemic cells. Tanshione II-A induced a dose- and time-dependent DNA fragmentation into the multiples of 180 bp and specific proteolytic cleavage of poly(ADP-ribose) polymerase in both cell lines. PI-staining and flow cytometry analysis of K562 cells following Tanshione II-A treatment showed an increase of the cells possessing hypodiploid DNA indicative of apoptotic state of cells. Caspase-3 activity was significantly increased during Tanshinone II-A treatment of both HL60 and K562 cells, whereas caspase-1 activity was not changed. These results suggest that Tanshione II-A induced HL60 and K562 cellular apoptosis that may be associated with the selective members of caspase family. Copyright 2000 Academic Press.


Asunto(s)
Humanos , Antineoplásicos Fitogénicos/farmacología , Antineoplásicos Fitogénicos/química , Apoptosis/fisiología , Caspasas/metabolismo , Caspasas/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/química , Activación Enzimática/efectos de los fármacos , Células HL-60/patología , Células HL-60/metabolismo , Células HL-60/efectos de los fármacos , Lamiaceae/química , Leucemia/patología , Leucemia/metabolismo , Leucemia/tratamiento farmacológico , Leucemia Eritroblástica Aguda/patología , Leucemia Eritroblástica Aguda/metabolismo , Leucemia Eritroblástica Aguda/tratamiento farmacológico , Fenantrenos/farmacología , Fenantrenos/química , Células Tumorales Cultivadas
10.
Bol. Soc. Bras. Hematol. Hemoter ; 16(167): 267-70, set.-dez. 1994. tab, graf
Artículo en Portugués | LILACS | ID: lil-201495

RESUMEN

O emprego de quimioterapia em tumores de alta replicaçäo celular é responsável pela liberaçäo de constituintes celulares, que podem levar a sérias alteraçöes metabólicas. Estas alteraçöes compreendem distúrbios no metabolismo do: potássio, cálcio, fosfato, uréia e ácido úrico; que caracterizam a SINDROME de LISE TUMORAL AGUDA (SLTA). No período de 29/03/93 a 23/08/93, foram estudados 20 pacientes com hemopatias malignas, com indicaçäo de tratamento poliquimioterápico. Estes pacientes receberam hiper-hidrataçäo com 2000ml/m2 de soluçäo fisiológico 0,9 por cento e alopurinol 200mg/m2 iniciando-se no dia anterior até o último dia de quimioterapia. O diagnóstico de SLTA foi considerado nos pacientes que nos 4 dias do tratamento, apresentaram duas ou mais das seguintes alteraçöes metabólicas: aumento de 25 por cento nos níveis de potássio, ácido úrico, uréia e fosfato; ou diminuiçäo de 25 por cento no nível de cálcio sérico. A SINDROME DE LISE TUMORAL AGUDA CLINICA (SLTAC), foi definida como SLTAC, associada a condiçöes clínicas que implicassem em risco de vida nenhum dos nossos pacientes apresentou SLTAC e apenas 30 por cento desenvolveram SLTAL, demonstrando que este esquema de tratamento foi efetivo.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Enfermedad de Hodgkin/patología , Leucemia Mieloide/patología , Leucemia/patología , Linfoma no Hodgkin/patología , Síndrome de Lisis Tumoral/epidemiología , Ácido Úrico/metabolismo , Enfermedad Aguda , Calcio/metabolismo , Enfermedad de Hodgkin/metabolismo , Enfermedad de Hodgkin/tratamiento farmacológico , Fluidoterapia , Incidencia , Leucemia Mieloide/tratamiento farmacológico , Leucemia Mieloide/metabolismo , Leucemia/tratamiento farmacológico , Leucemia/metabolismo , Linfoma no Hodgkin/metabolismo , Linfoma no Hodgkin/tratamiento farmacológico , Fosfatos/metabolismo , Potasio/metabolismo , Síndrome de Lisis Tumoral/tratamiento farmacológico , Urea/metabolismo
11.
Journal of Korean Medical Science ; : 413-419, 1993.
Artículo en Inglés | WPRIM | ID: wpr-89027

RESUMEN

We attempted to study the role of protein tyrosine kinase (PTK) and protein kinase C (PKC) in the cascade of phosphorylation of ribosomal protein S6 during differentiation of leukemic cells (HL-60, THP-1, and RWLeu-4). Neither activation nor inhibition of colony stimulating factor-1 (CSF-1) receptor's PTK activity with CSF-1 or genistein respectively affected the phosphorylation of S6. However, vanadate which is a protein tyrosine phosphatase (PTP) inhibitor showed enhancement of S6 phosphorylation. Dimethylsulfoxide which does not affect either PTK or PKC demonstrated no change in S6 phosphorylation. PKC activation by acute 12-0-tetradecanoyl phorbol-13-acetate (TPA) treatment induced monocytic differentiation and S6 phosphorylation. Surprisingly, the more prominent phosphorylation of S6 protein was observed in PKC-depleted cells by prolonged TPA treatment. Our results suggest that PTK/PTP play a lesser role in S6 phosphorylation of HL-60 cells than PKC does. In addition, two different mechanisms seem to be involved in TPA-induced S6 phosphorylation during HL-60 differentiation: PKC activation by acute TPA treatment and PKC depletion which may lead to the synthesis of some endogenous protein responsible for the differentiation by chronic TPA treatment.


Asunto(s)
Humanos , Diferenciación Celular , Leucemia/metabolismo , Factor Estimulante de Colonias de Macrófagos/farmacología , Fosforilación , Proteína Quinasa C/fisiología , Proteínas Tirosina Quinasas/fisiología , Proteína S6 Ribosómica , Proteínas Ribosómicas/metabolismo , Acetato de Tetradecanoilforbol/farmacología , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA